menu
    • menu

    Company profile for HRA Pharma Rare Disease

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HRA Pharma Rare Diseases is dedicated to bringing the best care and services to people living with rare diseases and is committed to supporting healthcare professionals all over the world. We have over 15 years’ experience in rare and ultra-rare diseases and are passionate about improving the lives of people affected by these conditions. We recognise that people living with rare diseases often have severe and potentially lif...
    HRA Pharma Rare Diseases is dedicated to bringing the best care and services to people living with rare diseases and is committed to supporting healthcare professionals all over the world. We have over 15 years’ experience in rare and ultra-rare diseases and are passionate about improving the lives of people affected by these conditions. We recognise that people living with rare diseases often have severe and potentially life-threatening disabilities that impact not only their quality of life, but also the lives of those who care for them.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HRA Pharma Rare DiseaseFrance Flag
    Country
    Country
    France
    Address
    Address
    200 avenue de Paris 92320 Châtillon
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hra-pharma-rare-diseases.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hra-pharma-rare-diseases/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations
    Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations

    02 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/perrigo-reports-second-quarter-2024-financial-results-from-continuing-operations-302213348.html

    PR NEWSWIRE
    02 Aug 2024
    Share Share
    Perrigo Completes Divestment of HRA Pharma Rare Diseases Business
    Perrigo Completes Divestment of HRA Pharma Rare Diseases Business

    10 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/perrigo-completes-divestment-of-hra-pharma-rare-diseases-business-302193470.html

    PR NEWSWIRE
    10 Jul 2024
    Share Share
    Perrigo agrees to sell rare disease unit to Esteve for €275 million
    Perrigo agrees to sell rare disease unit to Esteve for €275 million

    26 Apr 2024

    // PRESS RELEASE

    https://www.esteve.com/global/news/esteve-signs-a-binding-offer-to-acquire-hra-pharma-rare-diseases-a-perrigo-company-affiliate

    PRESS RELEASE
    26 Apr 2024
    Share Share
    Perrigo to Divest HRA Pharma Rare Diseases for Up to €275M
    Perrigo to Divest HRA Pharma Rare Diseases for Up to €275M

    25 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/perrigo-receives-binding-offer-to-divest-its-hra-pharma-rare-diseases-business-for-up-to-275-million-302127347.html

    PR NEWSWIRE
    25 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search